Statistics for Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.

Total visits

views
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status. 122

Total visits per month

views
marzo 2024 2
abril 2024 7
mayo 2024 3
junio 2024 0
julio 2024 0
agosto 2024 0
septiembre 2024 0

File Visits

views
3.- Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.pdf 19